Website Header with Language Selector and Dropdowns
Watermark

(R)-Letermovir Ethyl Ester


Catalog Number: CL-LRVR-01
CAS No.: 2864441-55-2
Mol.F: C31H32F4N4O4
Mol.W: 600.6
Inv. Status: Custom Synthesis

Chemical Name: Ethyl (R)-2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-(4-(3-methoxyphenyl)piperazin-1-yl)-3,4 -dihydroquinazolin-4-yl)acetate.

Country of Origin: India

Product Category: Letermovir Impurities


(R)-Letermovir Ethyl Ester is identified by CAS No. 2864441-55-2 and is chemically known as Ethyl (R)-2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-(4-(3-methoxyphenyl)piperazin-1-yl)-3,4 -dihydroquinazolin-4-yl)acetate.

(R)-Letermovir Ethyl Ester is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Letermovir.

Page Keywords: Buy (R)-Letermovir Ethyl Ester | Purchase (R)-Letermovir Ethyl Ester | (R)-Letermovir Ethyl Ester suppliers | (R)-Letermovir Ethyl Ester manufacturers | (R)-Letermovir Ethyl Ester price | (R)-Letermovir Ethyl Ester Importer | (R)-Letermovir Ethyl Ester Exporter

Enquiry Now

Personal Details

Product Details

Related Products

CAT No: CL-LRVR-02
CAS No: NA
Mol Wt: 572.6
Mol F: C29H28F4N4O4
Inv. Status: Custom Synthesis
CAT No: CL-LRVR-03
CAS No: NA
Mol Wt: 572.6
Mol F: C29H28F4N4O4
Inv. Status: Custom Synthesis
CAT No: CL-LRVR-04
CAS No: NA
Mol Wt: 572.6
Mol F: C29H28F4N4O4
Inv. Status: Custom Synthesis
CAT No: CL-LRVR-05
CAS No: 917389-32-3
Mol Wt: 572.6
Mol F: C29H28F4N4O4
Inv. Status: Custom Synthesis
CAT No: CL-LRVR-06
CAS No: 2758792-79-7
Mol Wt: 600.6
Mol F: C31H32F4N4O4
Inv. Status: Custom Synthesis
CAT No: CL-LRVR-07
CAS No: NA
Mol Wt: 744.8
Mol F: C40H43F3N6O5
Inv. Status: Custom Synthesis
CAT No: CL-LRVR-08
CAS No: NA
Mol Wt: 618.7
Mol F: C34H36F2N4O5
Inv. Status: Custom Synthesis
Subscribe for news letter:
  

© Cleanchem Laboratories LLP. All Rights Reserved.